Europe — EMA

Palonosetron Dr. Reddy’s

Palonosetron, the active ingredient in Palonosetron Dr. Reddy’s, is a selective 5-HT3 receptor antagonist presented as a sterile injectable solution for intravenous use.

Palonosetron

Request sourcing

Pack/s

What is Palonosetron?

Palonosetron, the active ingredient in Palonosetron Dr. Reddy’s, is a selective 5-HT3 receptor antagonist presented as a sterile injectable solution for intravenous use. It is used to prevent nausea and vomiting associated with chemotherapy and postoperative settings in adult patients. GNH USA supplies Palonosetron Dr. Reddy’s as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and oncology centres worldwide.

GNH USA supplies Palonosetron Dr. Reddy’s as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and oncology centres worldwide.

What is Palonosetron used for?

Palonosetron is a long‑acting 5‑HT3 receptor antagonist that is employed in the prevention of nausea and vomiting in several clinical contexts.

- Chemotherapy‑induced nausea and vomiting (CINV): Reduces the incidence of acute and delayed CINV in adult patients receiving highly emetogenic chemotherapy. - Post‑operative postoperative N/V (POV) : S a a

- a t t

- - a. - . - . - . - . - . - . - . - . - . - . - . - . - . - . - . - . - . - .\n- . - . - . - . - . - - . - . - . - . - . - . - . - . - . - . - . - . - - - - - """\

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →